Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Mepacrine (Primary) ; Capecitabine
- Indications Colorectal cancer
- Focus Therapeutic Use
- 26 Jan 2017 Planned End Date changed from 1 Apr 2016 to 1 Jun 2017.
- 26 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 24 Apr 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.